1. Tibial perivascular epithelioid cell tumour (PEComa). A case report and literature review.
- Author
-
Técualt-Gómez R, Atencio-Chan A, Amaya-Zepeda RA, Cario-Méndez AG, González-Valladares R, and Rodríguez-Franco JH
- Subjects
- Bone Neoplasms chemistry, Bone Neoplasms diagnostic imaging, Bone Neoplasms therapy, Chemotherapy, Adjuvant, Cisplatin administration & dosage, Epirubicin administration & dosage, Humans, Male, Perivascular Epithelioid Cell Neoplasms chemistry, Perivascular Epithelioid Cell Neoplasms diagnostic imaging, Perivascular Epithelioid Cell Neoplasms therapy, Young Adult, Bone Neoplasms pathology, Perivascular Epithelioid Cell Neoplasms pathology, Tibia diagnostic imaging, Tibia pathology, Tibia surgery
- Abstract
Introduction: Perivascular epithelioid cell (PEC) is a cell type constantly present in a group of tumours including angiomyolipoma (AML), clear-cell «sugar» tumour (CCST) of the lung and extrapulmonary sites, lymphangioleiomyomatosis (LAM), and clear-cell tumours of other anatomical sites. It has morphologic distinctive features: epithelioid appearance with a clear to granular cytoplasm, a round to oval, centrally located nucleus and an inconspicuous nucleolus. Immunohistochemically, PEC expresses myogenic and melanocytic markers. Eleven cases of primary bone PEComa presentation have been described since 2002., Objective: To report a case of primary bone perivascular epithelioid cell tumour., Case Report: 24 year-old male presented with pain. X-ray revealed an osteolytic lesion at right proximal tibia with soft tissue extension. Evaluation of slides identified a bony perivascular epithelioid cell tumour without immunohistochemical study confirmation., Results: Patient was treated by surgical excision and adjuvant chemotherapy (epirubicin/cysplatin). After two years of follow-up the patient remains disease free., Conclusions: This is the first-case report in Latin America. Immunohistochemical stains were negative and we believe it may be due to non-described ethnic variations., (Copyright © 2018 SECOT. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF